Lessons From Fed. Circ. Ruling On Lung Disease Patent
The U.S. Court of Appeals for the Federal Circuit's Dec. 22, 2022, Genentech Inc. v. Sandoz Inc. decision includes two separate and interesting holdings involving patents claiming methods of varying doses...To view the full article, register now.
Already a subscriber? Click here to view full article